Cite
HARVARD Citation
Arena, V. et al. (2019). ER−/PR+/HER2− breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases. Breast journal. 25 (3), pp. 381-385. [Online].